Literature DB >> 11150050

Fragmentation of the Québec population genetic pool (Canada): evidence from the genetic contribution of founders per region in the 17th and 18th centuries.

A Gagnon1, E Heyer.   

Abstract

The 6 million French-Canadians of Québec derive from a relatively small number of founders. Consequently, some hereditary diseases, which may or may not present a worldwide distribution, have been detected in high frequency in this population. Several studies, however, indicate a nonuniform distribution of these diseases through the population, suggesting that the French-Canadian founder effect has been geographically stratified. Here we explore this stratification by using a demographic database, the Population Register of Early Québec, that contains almost all birth, marriage, and death certificates (>712,000) recorded in parish registers between 1608-1800. In this database, every genealogical link has been traced back to the founders of the population, so that we can compute the genetic contribution of founder per region, and then account for the early events that have shaped the distribution of diseases. Ten regions, comprising varying numbers of parishes, have been selected. We first describe each region in terms of homogeneity and concentration of its gene pool. For this purpose, a new concept is introduced, the founders' uniform contribution number (FUN), i.e., the number of founders a population would have if all its founders had an equal contribution. Second, we estimate genetic similarity between regions on the basis of differential genetic contribution. To classify the regions, we use principal component and cluster analysis. Our results show a tripartite clustering of the population, and invite us to reconsider the results obtained from biomolecular and clinical studies, which show a bipartite clustering. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11150050     DOI: 10.1002/1096-8644(200101)114:1<30::AID-AJPA1003>3.0.CO;2-L

Source DB:  PubMed          Journal:  Am J Phys Anthropol        ISSN: 0002-9483            Impact factor:   2.868


  9 in total

1.  A "Fille du Roy" introduced the T14484C Leber hereditary optic neuropathy mutation in French Canadians.

Authors:  Anne-Marie Laberge; Michele Jomphe; Louis Houde; Helene Vezina; Marc Tremblay; Bertrand Desjardins; Damian Labuda; Marc St-Hilaire; Carol Macmillan; Eric A Shoubridge; Bernard Brais
Journal:  Am J Hum Genet       Date:  2005-06-13       Impact factor: 11.025

2.  Genome-wide association study for Crohn's disease in the Quebec Founder Population identifies multiple validated disease loci.

Authors:  John V Raelson; Randall D Little; Andreas Ruether; Hélène Fournier; Bruno Paquin; Paul Van Eerdewegh; W E C Bradley; Pascal Croteau; Quynh Nguyen-Huu; Jonathan Segal; Sophie Debrus; René Allard; Philip Rosenstiel; Andre Franke; Gunnar Jacobs; Susanna Nikolaus; Jean-Michel Vidal; Peter Szego; Nathalie Laplante; Hilary F Clark; René J Paulussen; John W Hooper; Tim P Keith; Abdelmajid Belouchi; Stefan Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-05       Impact factor: 11.205

3.  Genomic and genealogical investigation of the French Canadian founder population structure.

Authors:  Marie-Hélène Roy-Gagnon; Claudia Moreau; Claude Bherer; Pascal St-Onge; Daniel Sinnett; Catherine Laprise; Hélène Vézina; Damian Labuda
Journal:  Hum Genet       Date:  2011-01-15       Impact factor: 4.132

4.  Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.

Authors:  Jacques Simard; Martine Dumont; Anne-Marie Moisan; Valérie Gaborieau; Hélène Malouin; Francine Durocher; Jocelyne Chiquette; Marie Plante; Denise Avard; Paul Bessette; Claire Brousseau; Michel Dorval; Béatrice Godard; Louis Houde; Yann Joly; Marie-Andrée Lajoie; Gilles Leblanc; Jean Lépine; Bernard Lespérance; Hélène Vézina; Jillian Parboosingh; Roxane Pichette; Louise Provencher; Josée Rhéaume; Daniel Sinnett; Carolle Samson; Jean-Claude Simard; Martine Tranchant; Patricia Voyer; Douglas Easton; Sean V Tavtigian; Bartha-Maria Knoppers; Rachel Laframboise; Peter Bridge; David Goldgar
Journal:  J Med Genet       Date:  2006-08-11       Impact factor: 6.318

5.  Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer.

Authors:  Luca Cavallone; Suzanna L Arcand; Christine M Maugard; Serge Nolet; Louis A Gaboury; Anne-Marie Mes-Masson; Parviz Ghadirian; Diane Provencher; Patricia N Tonin
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

6.  The Genetic and Molecular Analyses of RAD51C and RAD51D Identifies Rare Variants Implicated in Hereditary Ovarian Cancer from a Genetically Unique Population.

Authors:  Wejdan M Alenezi; Larissa Milano; Caitlin T Fierheller; Corinne Serruya; Timothée Revil; Kathleen K Oros; Supriya Behl; Suzanna L Arcand; Porangana Nayar; Dan Spiegelman; Simon Gravel; Anne-Marie Mes-Masson; Diane Provencher; William D Foulkes; Zaki El Haffaf; Guy Rouleau; Luigi Bouchard; Celia M T Greenwood; Jean-Yves Masson; Jiannis Ragoussis; Patricia N Tonin
Journal:  Cancers (Basel)       Date:  2022-04-30       Impact factor: 6.575

7.  GENLIB: an R package for the analysis of genealogical data.

Authors:  Héloïse Gauvin; Jean-François Lefebvre; Claudia Moreau; Eve-Marie Lavoie; Damian Labuda; Hélène Vézina; Marie-Hélène Roy-Gagnon
Journal:  BMC Bioinformatics       Date:  2015-05-15       Impact factor: 3.169

8.  Native American admixture in the Quebec founder population.

Authors:  Claudia Moreau; Jean-François Lefebvre; Michèle Jomphe; Claude Bhérer; Andres Ruiz-Linares; Hélène Vézina; Marie-Hélène Roy-Gagnon; Damian Labuda
Journal:  PLoS One       Date:  2013-06-12       Impact factor: 3.240

9.  Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.

Authors:  Marc Tischkowitz; Nelly Sabbaghian; Nancy Hamel; Carly Pouchet; William D Foulkes; Anne-Marie Mes-Masson; Diane M Provencher; Patricia N Tonin
Journal:  BMC Med Genet       Date:  2013-01-09       Impact factor: 2.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.